Cargando…
Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality of Coronary Artery Bypass Grafting
BACKGROUND: There is controversy over the potential benefits/harms of the usage of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) as regards the postoperative mortality of coronary artery bypass grafting (CABG). This study investigates the correlation betwee...
Autores principales: | Sharafi, Ahmad, Davoodi, Saeed, Karimi, Abbas Ali, Ahmadi, Hosein, Abbasi, Kyomars, Sheikh Fathollahi, Mahmood, Bina, Payvand, Soleymanzadeh, Maryam, Fehri, Arezoo, Davaran, Saeid, Jahangheeri, Siroos, Kassaian, Seyed Ebrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434968/ https://www.ncbi.nlm.nih.gov/pubmed/26005485 |
Ejemplares similares
-
Author`s Reply
por: Mansourian, Soheil, et al.
Publicado: (2015) -
Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to/less than 30%)
por: Mansourian, Soheil, et al.
Publicado: (2016) -
Author’s Reply
por: Mansourian, Soheil, et al.
Publicado: (2015) -
Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
por: Khalili, Azadeh, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)